Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

300 INTERFERON ALFA
(2000): Savoye G+, Gastroenterol Clin Biol 24(6-7), 679 (with
ribavirin)
(2000): Vallina E+, An Med Interna 17(10), 538
(1999): Pietropaoli A+, Chest 116, 569
(1998): Kikawada M+, Respirology 3(1), 41
(1996): Teragawa H+, Intern Med 35(1), 19
(1993): Blum L+, Rev Med Interne (Paris) (French) 14, 1161
Scleroderma
(2004): Solans R+, Clin Exp Rheumatol 22(5), 625
Seborrheic dermatitis
(2004): Guillot B+, Dermatology 208(1), 49 (3 cases)
(1986): Quesada JR+, Lancet 1, 1466
Systemic sclerosis
(2002): Beretta L+, Br J Dermatol 147(2), 385
Telangiectasia
(1989): Dreno B+, AnnInternMed111, 95
Toxicity (sic)
(1993): Miglino M+, Haematologica 78(6), 411
(1989): Dreno B+, AnnInternMed111, 95
Ulcerations
(1992): Orlow SJ+, Arch Dermatol 128, 566
Urticaria (10%)
(2004): Guillot B+, Dermatology 208(1), 49 (10 cases)
Hair
Hair – alopecia (1–10%)
(2004): Guillot B+, Dermatology 208(1), 49 (48%)
(2002): Alpsoy E+, Arch Dermatol 138, 467
(2001): Zucker DM+, Gastroenterol Nurs 24(4), 192 (with
ribavirin)
(2000): Stafford-Fox V+, Clin J Oncol Nurs 4(4), 164
(1997): Brehler R+, JAmAcadDermatol36, 983 (passim)
(1995): Chang LW+, Cutis 56, 144
(1994): Czarnetzki BM+, JAmAcadDermatol30, 500
(1992): Tosti A+, Dermatology 184, 124
(1989): Olsen EA+, JAmAcadDermatol20, 395
(1987): Werter MJBP, Ned Tijdschr Geneeskd (Dutch) 131, 2081
Hair – alopecia areata
(1999): Kernland KH+, Dermatology 198, 418
Hair – curly
(2006): Tinio P+, Skinmed 5(1), 50 (with ribavirin)
Hair – hypertrichosis
(1996): Ariyoshi K+, Am J Hematol 53, 50 (eyebrows)
(1990): Berglund EF+, South Med J 83, 363
(1984): Foon KA+, NEnglJMed19, 1259 (eyelashes)
Hair – pigmentation
(2004): Guillot B+, Dermatology 208(1), 49 (18%)
(1996): Fleming CJ+, Br J Dermatol 135, 337
(1995): Bernstein D+, Am J Gastroenterol 90, 1176 (canities)
Hair – straight
(2003): Lanigan SW, Br J Dermatol 148, 595 (with ribavirin)
(2002): Bessis D+, Br J Dermatol 147(2), 392
Eyes
Eyelashes – hypertrichosis
(2002): Misery L, J Interferon Cytokine Res 22, 881
(2000): Ozdogan M+, J Interferon Cytokine Res 20, 633
Retinopathy
(2006): Prescrire Int 15(82), 61
(2006): Okuse C+, World J Gastroenterol 12(23), 3756
Other
Candidiasis (1%)
Chills
(2002): Alpsoy E+, Arch Dermatol 138, 467
(2000): Cornejo P+, Arch Dermatol 136, 429
(2000): Shenefelt PD+, Arch Dermatol 136, 837
Embolia cutis medicamentosa (Nicolau syndrome)
(2003): Reding EL+, JAmAcadDermatol48(3), 472 (passim)
Fever
(2002): Goldberg JS+, Cancer 95(6), 1220 (2 cases)
(2002): Wirth S+, Hepatology 36(5), 1280 (with ribavirin)
Hot flashes (1%)
Hypersensitivity
(2001): Beckman DB+, Allergy 56(8), 806
Infections
(2002): Goldberg JS+, Cancer 95(6), 1220 (1 case)
Injection-site alopecia
(2000): Sparsa A+, Rev Med Interne 21(9), 756
(1999): Lang AM+, Arch Dermatol 135, 1127
Injection-site eczematous eruption
(2004): Guillot B+, Dermatology 208(1), 49 (39%)
Injection-site erythema
(2000): Sparsa A+, Rev Med Interne 21(9), 756
(1995): Chang LW+, Cutis 56, 144
Injection-site induration
(2000): Sparsa A+, Rev Med Interne 21(9), 756
(2000): Stafford-Fox V+, Clin J Oncol Nurs 4(4), 164
(1997): Siegel M, New York, NY (from Internet) (observation)
(1995): Chang LW+, Cutis 56, 144
Injection-site necrosis
(2000): Sparsa A+, Rev Med Interne 21(9), 756
(2000): Stafford-Fox V+, Clin J Oncol Nurs 4(4), 164
(1998): Krainick U+, J Interferon Cytokine Res 18, 823
(1997): Weinberg JM+, Acta Derm Venereol (Stockh) 77, 146
(1996): Konohana A+, JAmAcadDermatol35, 788
(1996): Kontochristopoulos G+, JHepatol25, 271